Endometrial Cancer Trial, Recruiting NCT06968871 Sponsor: National Taiwan University Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06968871
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 25 or older

Who may not be able to join:

  • People who are currently having their menstrual period
  • People who are pregnant
  • People who have difficulty understanding numbered pain rating scales
  • People who have an active cancer diagnosis — meaning cancer that was diagnosed or treated in the last 6 months, or cancer that has come back, spread to nearby areas, or spread to other parts of the body
  • People who have previously had their uterus removed (hysterectomy), any surgery in the pelvic area, or radiation therapy to that area
  • People who currently have an active infection of the vagina or uterus
  • People who have taken any pain relief medication within the last 24 hours before the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chien-Hsieh Chiang, MD, MPH, PhD, National Taiwan University Hospital & College of Medicine

Phone: 886 + 972651864

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 December 2030

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

3-year cervical cancer screening participation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov